These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 11054389)
1. Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Czaja AJ; Lindor KD Gastroenterology; 2000 Nov; 119(5):1312-6. PubMed ID: 11054389 [TBL] [Abstract][Full Text] [Related]
2. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Angulo P; Jorgensen RA; Keach JC; Dickson ER; Smith C; Lindor KD Hepatology; 2000 Feb; 31(2):318-23. PubMed ID: 10655252 [TBL] [Abstract][Full Text] [Related]
3. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051 [TBL] [Abstract][Full Text] [Related]
4. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Manns MP; Woynarowski M; Kreisel W; Lurie Y; Rust C; Zuckerman E; Bahr MJ; Günther R; Hultcrantz RW; Spengler U; Lohse AW; Szalay F; Färkkilä M; Pröls M; Strassburg CP; Gastroenterology; 2010 Oct; 139(4):1198-206. PubMed ID: 20600032 [TBL] [Abstract][Full Text] [Related]
5. Budesonide induces complete remission in autoimmune hepatitis. Csepregi A; Röcken C; Treiber G; Malfertheiner P World J Gastroenterol; 2006 Mar; 12(9):1362-6. PubMed ID: 16552802 [TBL] [Abstract][Full Text] [Related]
6. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP; J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723 [TBL] [Abstract][Full Text] [Related]
7. Budesonide for the treatment of autoimmune hepatitis. Snider KR; Potter TG Ann Pharmacother; 2011 Sep; 45(9):1144-50. PubMed ID: 21878659 [TBL] [Abstract][Full Text] [Related]
8. The use of budesonide in the treatment of autoimmune hepatitis in Canada. Zandieh I; Krygier D; Wong V; Howard J; Worobetz L; Minuk G; Witt-Sullivan H; Yoshida EM Can J Gastroenterol; 2008 Apr; 22(4):388-92. PubMed ID: 18414714 [TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Cino M; Greenberg GR Am J Gastroenterol; 2002 Apr; 97(4):915-21. PubMed ID: 12003427 [TBL] [Abstract][Full Text] [Related]
10. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Leuschner M; Maier KP; Schlichting J; Strahl S; Herrmann G; Dahm HH; Ackermann H; Happ J; Leuschner U Gastroenterology; 1999 Oct; 117(4):918-25. PubMed ID: 10500075 [TBL] [Abstract][Full Text] [Related]
11. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis]. Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335 [No Abstract] [Full Text] [Related]
14. Budesonide as first-line therapy for non-cirrhotic autoimmune hepatitis in children: a decision analysis. Mohammad S Scand J Gastroenterol; 2016; 51(6):753-62. PubMed ID: 26762679 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis. Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224 [TBL] [Abstract][Full Text] [Related]
16. Budesonide for juvenile autoimmune hepatitis? Not yet. Mieli-Vergani G; Vergani D J Pediatr; 2013 Nov; 163(5):1246-8. PubMed ID: 23932214 [No Abstract] [Full Text] [Related]